Drug intelligence / Profile preview

macrogol

Development stage
Phase 4
Modality
Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Administration
Oral
01

Overview

**Macrogol** is the International Nonproprietary Name for polyethylene glycol, a non-absorbed synthetic polyether polymer used pharmacologically as an **osmotic laxative**. After oral administration, it retains water in the intestinal lumen, softening stool and increasing stool volume, which facilitates bowel movements; it does not act through a defined receptor target. The name is chemically non-specific because marketed products use different polymer molecular-weight ranges, most commonly macrogol 3350 or macrogol 4000, with or without electrolytes. Macrogol products are used for constipation and fecal impaction, while higher-volume macrogol-containing preparations are used for bowel cleansing before colonoscopy or surgery. ([ema.europa.eu](https://www.ema.europa.eu/en/documents/other/public-summary-evaluation-proposed-paediatric-investigation-plan-macrogol-3350-treatment-constipation_en.pdf))

Brand names
MiraLAXGaviLaxGialaxGlycoLaxHealthylaxSmooth LAXVita HealthClearLaxNatura-LaxRestoraLAXMoviPrep
Other names
polyethylene glycolPEG

Beyond the preview

Go deeper on macrogol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on macrogol.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call